Here, we explore how CIBRA can be used to identify the most impactful mutation type by systematically testing different SNVs, classified according to their coding effect, for known tumor suppressor genes (APC and TP53) and oncogenes (BRAF) in metastasized microsatellite stable CRC. Here, TP53 is linked to colorectal carcinoma.